Effects of a chronic l‐arginine supplementation on the arginase pathway in aged rats

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental Gerontology

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exger.2017.01.023PMID 28132871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes.

  2016cited by this paper
• Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation

  2016influential reference
• Arginase I expression is upregulated by dietary restriction in the liver of mice as a function of age

  2015cited by this paper
• Formulation, preclinical and clinical evaluation of a new submicronic arginine respiratory fluid for treatment of chronic obstructive pulmonary disorder

  2015cited by this paper
• Nitric Oxide-Related Biological Pathways in Patients with Major Depression

  2015cited by this paper
• Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling

  2014cited by this paper
• Single- and multiple-dose pharmacokinetics of arginase inhibitor Nω-hydroxy-nor-L-arginine, and its effect on plasma amino acids concentrations in Wistar rats.

  2014cited by this paper
• Functions and Mechanisms of Arginase in Age-Associated Cardiovascular Diseases

  2013influential reference
• Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

  2013cited by this paper
• Deficiency of ovarian ornithine decarboxylase contributes to aging‐related egg aneuploidy in mice

  2013cited by this paper
• Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.

  2013cited by this paper
• Cognitive enhancement in middle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine.

  2013cited by this paper
• Regional variations and age-related changes in arginine metabolism in the rat brain stem and spinal cord.

  2013cited by this paper
• Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity

  2013cited by this paper
• Effect of stroke on arginase expression and localization in the rat brain

  2013cited by this paper
• Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats.

  2012cited by this paper
• Arginine de novo and nitric oxide production in disease states.

  2012cited by this paper
• Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve

  2012cited by this paper
• Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity

  2012cited by this paper
• Arginases and arginine deficiency syndromes

  2012cited by this paper
• S-Nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase

  2011cited by this paper
• Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.

  2011cited by this paper
• OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.

  2011cited by this paper
• Paradoxical effect of L-arginine: acceleration of endothelial cell senescence.

  2009cited by this paper
• L-arginine and Alzheimer's disease.

  2009cited by this paper
• Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

  2009cited by this paper
• Modulating human aging and age-associated diseases.

  2009cited by this paper
• Recent advances in arginine metabolism: roles and regulation of the arginases.

  2009cited by this paper
• Arginase and vascular aging.

  2008influential reference
• Ageing diminishes endothelium‐dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles

  2008cited by this paper
• Response to Letter Regarding Article, “L-Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm”

  2008cited by this paper
• Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.

  2007cited by this paper
• Arginine metabolism: boundaries of our knowledge.

  2007influential reference
• Mechanisms of endothelial dysfunction induced by aging: role of arginase I.

  2007cited by this paper
• L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.

  2006cited by this paper
• Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats

  2006cited by this paper
• Recent advances in understanding endothelial dysfunction in atherosclerosis.

  2006cited by this paper
• Arginine metabolism in vascular biology and disease

  2005cited by this paper
• L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.

  2005cited by this paper
• Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats

  2005cited by this paper
• Protective effects of sodium orthovanadate in diabetic reticulocytes and ageing red blood cells of Wistar rats

  2004cited by this paper
• Age-related alterations of oxidative stress and arginase activity as a response to intestinal ischemia-reperfusion in rat kidney and liver.

  2003cited by this paper
• Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

  2003cited by this paper
• Vascular effects of dietary L-arginine supplementation.

  2002cited by this paper
• Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure.

  2001cited by this paper
• Increase of the ornithine decarboxylase/polyamine system and transglutaminase upregulation in the spinal cord of aged rats.

  2001cited by this paper
• Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.

  2000cited by this paper
• Arginine Intake and Risk of Coronary Heart Disease Mortality in Elderly Men

  2000cited by this paper
• EFFECTS OF VOLUNTARY EXERCISE AND L‐ARGININE ON THROMBOGENESIS AND MICROCIRCULATION IN STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS

  1999influential reference
• Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.

  1998influential reference
• Arginine metabolism: nitric oxide and beyond.

  1998cited by this paper
• Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function.

  1997cited by this paper
• Effects of long-term oral administration of L-arginine on the rat erectile response.

  1997influential reference
• Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging.

  1994cited by this paper
• Determination of arginase activity in macrophages: a micromethod.

  1994cited by this paper
• Aging alters ornithine decarboxylase and decreases polyamines in regenerating rat liver but putrescine replacement has no effect.

  1992cited by this paper
• Activity and modulation of ornithine decarboxylase and concentrations of polyamines in various tissues of rats as a function of age.

  1982cited by this paper
• Arginase inhibition.

  1981cited by this paper
• Changes of liver and kidney polyamine levels during ageing

  1975cited by this paper
• Changes of liver and kidney polyamine levels during aging.

  1975cited by this paper
• Effect of age on the activity of arginase of the liver and kidney cortex of rat.

  1969cited by this paper

• Declining nitric oxide bioavailability in cardiovascular aging: mechanistic insights and emerging interventions

  2025cites this paper
• The effects of a comparatively higher dose of 1000 mg/kg/d of oral L- or D-arginine on the L-arginine metabolic pathways in male Sprague-Dawley rats

  2023cites this paper
• Morphological evaluation of rat cerebellum following administration of nitrogen monoxide precursor and inhibitor

  2022cites this paper
• Механизмы нарушения метаболизма L-аргинина в эндотелиальных клетках

  2021cites this paper
• L-Arginine Reduces Nitro-Oxidative Stress in Cultured Cells with Mitochondrial Deficiency

  2021cites this paper
• The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells

  2021cites this paper
• Understanding the role of host metabolites in the induction of immune senescence: Future strategies for keeping the ageing population healthy

  2021cites this paper
• The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective

  2021cites this paper
• Arginase inhibitory properties of flavonoid compounds from the leaves of Mulberry (Morus alba, Moraceae).

  2020cites this paper
• Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine.

  2019cites this paper
• The role of arginase in aging: A systematic review.

  2019cites this paper
• Nutrient Compositions And Antioxidant Capacity Of E’jiao Gao

  2019cites this paper
• The effects of oral arginine on its metabolic pathways in Sprague–Dawley rats

  2019influential citation
• Understanding metabolic changes in aging bone marrow

  2018cites this paper
• Sirtuin Modulators and Brain Aging

  2018cites this paper
• Arginase Inhibitory, Antioxidant Activity and Pharmacognosy Study of Sterculia macrophylla Vent. Leaves

  2018cites this paper
• A relative L‐arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition

  2017cites this paper